The reviewed studies confirmed that sperm count, FSH level, and the inhibin-B/FSH ratio are appropriate tools to investigate fertility in male patients with HL or DLBCL treated with gonadotoxic therapies, showing changes related to stage of disease, number of cycles, and intensity of chemotherapy. This evidence concerns the gene BRD2 and diffuse large B-cell lymphoma.